AR053987A1 - Derivados de malonamida. proceso de obtencion y composiciones farmaceuticas. - Google Patents
Derivados de malonamida. proceso de obtencion y composiciones farmaceuticas.Info
- Publication number
- AR053987A1 AR053987A1 ARP050105106A ARP050105106A AR053987A1 AR 053987 A1 AR053987 A1 AR 053987A1 AR P050105106 A ARP050105106 A AR P050105106A AR P050105106 A ARP050105106 A AR P050105106A AR 053987 A1 AR053987 A1 AR 053987A1
- Authority
- AR
- Argentina
- Prior art keywords
- lower alkyl
- halogen
- pharmaceutical compositions
- cycloalkyl
- hydroxy
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D267/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D267/02—Seven-membered rings
- C07D267/08—Seven-membered rings having the hetero atoms in positions 1 and 4
- C07D267/12—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D267/14—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with one six-membered ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/553—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one oxygen as ring hetero atoms, e.g. loxapine, staurosporine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Hydrogenated Pyridines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Proceso de obtencion y composiciones farmacéuticas que los comprenden. Reivindicacion 1: Compuestos de la formula general (1) en la que R es halogeno, alquilo inferior o trifluorometilo; R1 es H, alquilo inferior o alquilo inferior sustituido por halogeno o hidroxi o es alquenilo inferior, -(CH2)n-cicloalquilo, -(CH2)n-COR' o es bencilo opcionalmente sustituido por halogeno o R' es alcoxi inferior, hidroxi o amino; R2 es H, alquilo inferior, trifluorometilo o cicloalquilo; R3 es alquilo inferior o alquilo inferior sustituido por halogeno o es bencilo opcionalmente sustituido por dos átomos de halogeno o es -(CH2)n-cicloalquilo o -(CH2)n-piridinilo; X es -CH2-, -CH(R4)-, -C(alquilo inferior)2-, -C(halogeno)(alquilo inferior)- o - CH(R4)-O-; R4 es alquilo, alquilo inferior, alcoxi inferior, hidroxi o -CH2-2-[1,3]dioxalano-; n es 0, 1 o 2; a sales de adicion de ácido farmacéuticamente aceptables de los mismos.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP04106395 | 2004-12-08 | ||
| EP05100816 | 2005-02-07 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR053987A1 true AR053987A1 (es) | 2007-05-30 |
Family
ID=36293585
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP050105106A AR053987A1 (es) | 2004-12-08 | 2005-12-07 | Derivados de malonamida. proceso de obtencion y composiciones farmaceuticas. |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US7211573B2 (es) |
| EP (1) | EP1828151B1 (es) |
| JP (1) | JP4979590B2 (es) |
| KR (1) | KR100890678B1 (es) |
| CN (1) | CN101072760B (es) |
| AR (1) | AR053987A1 (es) |
| AT (1) | ATE504580T1 (es) |
| AU (1) | AU2005313582B8 (es) |
| BR (1) | BRPI0518615A2 (es) |
| CA (1) | CA2589196A1 (es) |
| DE (1) | DE602005027388D1 (es) |
| DK (1) | DK1828151T3 (es) |
| HK (1) | HK1114840A1 (es) |
| IL (1) | IL183293A0 (es) |
| MX (1) | MX2007006504A (es) |
| NO (1) | NO20072609L (es) |
| NZ (1) | NZ555184A (es) |
| PL (1) | PL1828151T3 (es) |
| PT (1) | PT1828151E (es) |
| RU (1) | RU2402538C2 (es) |
| TW (1) | TWI349005B (es) |
| WO (1) | WO2006061136A2 (es) |
| ZA (1) | ZA200705018B (es) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2069317A2 (en) * | 2006-09-20 | 2009-06-17 | F. Hoffmann-Roche AG | 4-oxo-2,3,4,5-tetrahydro-benzo[b][1,4]diazepine derivatives |
| CN101622232A (zh) | 2007-02-02 | 2010-01-06 | 弗·哈夫曼-拉罗切有限公司 | 6-氧代-6,7-二氢-5h-二苯并[b,d]氮杂䓬-7-基衍生物 |
| US8741889B2 (en) * | 2008-01-11 | 2014-06-03 | Hoffmann-La Roche Inc | Method of treating non-small cell lung cancer and colon cancer with gamma-secretase inhibitor |
| BRPI0906831A2 (pt) * | 2008-01-11 | 2019-09-24 | Hoffmann La Roche | uso de um inibidor de gama-secretase para tratamento de câncer |
| WO2016198366A1 (en) | 2015-06-11 | 2016-12-15 | F. Hoffmann-La Roche Ag | Targeted notch pathway inhibitors |
| WO2019081486A1 (en) | 2017-10-24 | 2019-05-02 | Bayer Aktiengesellschaft | 4H-PYRROLO [3,2-C] PYRIDIN-4-ONE DERIVATIVES |
| US20220017456A1 (en) * | 2018-11-07 | 2022-01-20 | Chugai Seiyaku Kabushiki Kaisha | O-substituted serine derivative production method |
| EP3959211A1 (en) | 2019-04-24 | 2022-03-02 | Bayer Aktiengesellschaft | 4h-pyrrolo[3,2-c]pyridin-4-one compounds |
| US20220378762A1 (en) | 2019-04-24 | 2022-12-01 | Bayer Aktiengesellschaft | 4h-pyrrolo[3,2-c]pyridin-4-one derivatives |
| CA3137610A1 (en) | 2019-04-24 | 2020-10-29 | Bayer Aktiengesellschaft | 4h-pyrrolo[3,2-c]pyridin-4-one compounds |
| CN112300019A (zh) * | 2019-07-31 | 2021-02-02 | 华东师范大学 | 一种邻乙酰氨基苯丁酸类化合物的制备方法 |
| EP4126861A1 (en) | 2020-03-31 | 2023-02-08 | Bayer Aktiengesellschaft | 3-(anilino)-2-[3-(3-alkoxy-pyridin-4-yl]-1,5,6,7-tetrahydro-4h-pyrrolo[3,2-c]pyridin-4-one derivatives as egfr inhibitors for the treatment of cancer |
| JP2024508977A (ja) | 2021-03-09 | 2024-02-28 | ビーエーエスエフ ソシエタス・ヨーロピア | マロンアミド及び除草剤としてのその使用 |
| WO2023025855A1 (en) * | 2021-08-25 | 2023-03-02 | Basf Se | Herbicidal malonamides |
| CN117881667A (zh) * | 2021-08-31 | 2024-04-12 | 巴斯夫欧洲公司 | 含有稠环系的除草剂丙二酰胺 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2002241368A (ja) * | 1997-02-18 | 2002-08-28 | Shionogi & Co Ltd | 新規ベンゾラクタム誘導体およびそれを含有する医薬組成物 |
| AU4707999A (en) * | 1998-06-22 | 2000-01-10 | Elan Pharmaceuticals, Inc. | Compounds for inhibiting beta-amyloid peptide release and/or its synthesis |
| GB0012671D0 (en) | 2000-05-24 | 2000-07-19 | Merck Sharp & Dohme | Therapeutic agents |
| DE60327522D1 (de) * | 2002-05-29 | 2009-06-18 | Hoffmann La Roche | Bitoren der monoaminoxidase b |
| TW200502221A (en) * | 2002-10-03 | 2005-01-16 | Astrazeneca Ab | Novel lactams and uses thereof |
| WO2004069826A1 (en) | 2003-02-04 | 2004-08-19 | F. Hoffmann-La Roche Ag | Malonamide derivatives as gamma-secretase inhibitors |
| US7060698B2 (en) | 2003-05-19 | 2006-06-13 | Hoffmann-La Roche Inc. | Benzoxazepinone derivatives |
| ATE428698T1 (de) | 2003-09-09 | 2009-05-15 | Hoffmann La Roche | Die aktivität von gamma-secretase blockierende malonamidderivate |
| KR100884872B1 (ko) | 2003-10-06 | 2009-02-23 | 에프. 호프만-라 로슈 아게 | 감마-세크레타제 저해제로서 유용한 치환된다이벤조-아제핀 및 벤조-다이아제핀 유도체 |
-
2005
- 2005-11-30 US US11/289,176 patent/US7211573B2/en not_active Expired - Fee Related
- 2005-12-01 CA CA002589196A patent/CA2589196A1/en not_active Abandoned
- 2005-12-01 MX MX2007006504A patent/MX2007006504A/es active IP Right Grant
- 2005-12-01 CN CN2005800421635A patent/CN101072760B/zh not_active Expired - Fee Related
- 2005-12-01 DK DK05811672.4T patent/DK1828151T3/da active
- 2005-12-01 WO PCT/EP2005/012834 patent/WO2006061136A2/en active Application Filing
- 2005-12-01 JP JP2007544779A patent/JP4979590B2/ja not_active Expired - Fee Related
- 2005-12-01 BR BRPI0518615-3A patent/BRPI0518615A2/pt not_active IP Right Cessation
- 2005-12-01 KR KR1020077015604A patent/KR100890678B1/ko not_active IP Right Cessation
- 2005-12-01 DE DE602005027388T patent/DE602005027388D1/de active Active
- 2005-12-01 AU AU2005313582A patent/AU2005313582B8/en not_active Ceased
- 2005-12-01 NZ NZ555184A patent/NZ555184A/en not_active IP Right Cessation
- 2005-12-01 AT AT05811672T patent/ATE504580T1/de active
- 2005-12-01 RU RU2007120211/04A patent/RU2402538C2/ru not_active IP Right Cessation
- 2005-12-01 PL PL05811672T patent/PL1828151T3/pl unknown
- 2005-12-01 EP EP05811672A patent/EP1828151B1/en active Active
- 2005-12-01 PT PT05811672T patent/PT1828151E/pt unknown
- 2005-12-07 TW TW094143269A patent/TWI349005B/zh not_active IP Right Cessation
- 2005-12-07 AR ARP050105106A patent/AR053987A1/es unknown
-
2007
- 2007-05-17 IL IL183293A patent/IL183293A0/en unknown
- 2007-05-24 NO NO20072609A patent/NO20072609L/no not_active Application Discontinuation
- 2007-06-04 ZA ZA200705018A patent/ZA200705018B/xx unknown
-
2008
- 2008-04-29 HK HK08104728.3A patent/HK1114840A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| PL1828151T3 (pl) | 2011-09-30 |
| NZ555184A (en) | 2010-01-29 |
| AU2005313582B8 (en) | 2011-06-16 |
| NO20072609L (no) | 2007-06-19 |
| CA2589196A1 (en) | 2006-06-15 |
| JP4979590B2 (ja) | 2012-07-18 |
| RU2007120211A (ru) | 2009-01-20 |
| PT1828151E (pt) | 2011-06-16 |
| TW200626568A (en) | 2006-08-01 |
| DE602005027388D1 (de) | 2011-05-19 |
| AU2005313582A8 (en) | 2011-06-16 |
| CN101072760A (zh) | 2007-11-14 |
| HK1114840A1 (en) | 2008-11-14 |
| RU2402538C2 (ru) | 2010-10-27 |
| ATE504580T1 (de) | 2011-04-15 |
| DK1828151T3 (da) | 2011-05-16 |
| US20060122168A1 (en) | 2006-06-08 |
| MX2007006504A (es) | 2007-06-22 |
| EP1828151B1 (en) | 2011-04-06 |
| KR20070086979A (ko) | 2007-08-27 |
| BRPI0518615A2 (pt) | 2008-11-25 |
| JP2008522994A (ja) | 2008-07-03 |
| IL183293A0 (en) | 2007-09-20 |
| EP1828151A2 (en) | 2007-09-05 |
| WO2006061136A2 (en) | 2006-06-15 |
| ZA200705018B (en) | 2010-04-28 |
| WO2006061136A3 (en) | 2006-08-03 |
| US7211573B2 (en) | 2007-05-01 |
| TWI349005B (en) | 2011-09-21 |
| AU2005313582A1 (en) | 2006-06-15 |
| KR100890678B1 (ko) | 2009-03-26 |
| CN101072760B (zh) | 2011-12-28 |
| AU2005313582B2 (en) | 2011-06-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR053987A1 (es) | Derivados de malonamida. proceso de obtencion y composiciones farmaceuticas. | |
| EA200900358A1 (ru) | Энантиомерно чистые фосфоиндолы в качестве ингибиторов hiv | |
| DK1140745T3 (da) | Colchinolderivater som vaskulært skadelige midler | |
| RS50932B (sr) | N-oksidi kao prolekovi 4-fenil-piridinskih derivata koji su antagonisti nk1 receptora | |
| ATE397605T1 (de) | Nebivolol und dessen pharmazeutisch unbedenkliche salze, herstellungsverfahren und pharmazeutische zusammensetzungen von nebivolol | |
| BR0317294A (pt) | Composto, formulação farmacêutica, uso de um composto, métodos de prevenção e/ou tratamento de condições associadas com a glicogênio sintase quinase-3 e de prevenção e/ou tratamento de doenças, e, uso dos intermediários | |
| DK1814846T3 (da) | 11beta-HSD1-inhibitorer | |
| UY29312A1 (es) | Piperazin-1-carboxamidas n,4,sustituidas y sus derivados, composiciones que los contienen, procedimientos de preparación y aplicaciones | |
| MXPA04002338A (es) | Derivados de carbazol y su uso como antagonistas receptores del npy5. | |
| EA200700901A1 (ru) | Производные 2-амидо-4-фенилтиазола, их получение и применение в терапии | |
| ATE523498T1 (de) | Hiv-inhibierende 2-(4- cyanophenylamino)pyrimidinderivate | |
| AR054102A1 (es) | Derivados de fenil-piperazina-metanona. procesos de obtencion y composiciones farmaceuticas | |
| BRPI0409465A (pt) | derivados de carboxamida como agentes antidiabéticos | |
| EA200300071A1 (ru) | Терапевтический препарат для лечения невроза страха (тревоги) или депрессии и производные пиперазина | |
| BRPI0512086A (pt) | composto e os sais farmacologicamente aceitáveis do mesmo, composição farmacêutica, e, processo para a preparação de compostos | |
| AR029343A1 (es) | USO DE UN ANTAGONISTA DE NMDA DE BAJA AFINIDAD PARA EL TRATAMIENTO DE LA DEPRESIoN | |
| DE60105610D1 (en) | Pyrazinonderivate | |
| NO961077L (no) | Substituerte benzoltienylpiperaziner, deres anvendelse som medikamenter og fremgangsmåter for fremstilling | |
| BRPI0408467A (pt) | cromenonaindóis | |
| BR0214488A (pt) | Derivados de benzotiazol | |
| PA8545601A1 (es) | Derivados de 4-aminopirimidina | |
| EA200600022A1 (ru) | Применение производных бицикло [2.2.1] гептана для приготовления нейропротекторных фармацевтических композиций | |
| CO5590900A2 (es) | Fenilalquinos | |
| DE602005022698D1 (de) | Alkaloidverbindungen und ihre verwendung als antimalariamittel | |
| NO20020475D0 (no) | 2-aminotetralinderivater for terapi av glaukom |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |